https://www.selleckchem.com/pr....oducts/itacitinib-in
05). In the type 2 diabetes group and the obese group, aBMD was about 0.5 SDs lower for a given LBMI score compared with healthy weight control patients ( 0.05). Further, aBMD was lower in those with greater visceral fat (β = -0.121, = 0.047). These results suggest that type 2 diabetes may be detrimental to bone density around the age of peak bone mass. Given the increased fracture risk in adults with type 2 diabetes, there is a pressing need for longitudinal studies aimed at understanding the influence of diabetes on
Like
Comment
Share
